| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |